An Efficacy Study of Stain Control of a 67% Sodium Bicarbonate Containing Toothpaste on Chlorhexidine Tooth Staining
A Study to Evaluate the Effect of a 67% Sodium Bicarbonate Containing Toothpaste on Chlorhexidine Digluconate Tooth Staining
2 other identifiers
interventional
160
1 country
3
Brief Summary
The aim of this study is to compare the stain effect on teeth of twice daily brushing with a 67% sodium bicarbonate containing toothpaste versus standard toothpaste (not containing sodium bicarbonate) for six weeks whilst using a chlorhexidine digluconate 0.2% mouthwash.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Sep 2013
Shorter than P25 for phase_4
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 10, 2013
CompletedFirst Posted
Study publicly available on registry
October 14, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedResults Posted
Study results publicly available
November 3, 2014
CompletedMarch 3, 2015
February 1, 2015
2 months
October 10, 2013
July 17, 2014
February 12, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Modified Lobene Stain Index (MLSI) at Week 6
An assessment of the area and intensity of dental stain on the study teeth was performed using the MLSI after usage of 0.2% w/v chlorhexidine digluconate mouthwash for 6 weeks. The intensity of stain was scored on a scale of 0 to 3 (0 - no stain, 1- light stain, 2 - moderate stain, 3 - heavy stain). The area of stain was scored on the following scale: 0 - no stain; 1 - stain up to 1/3 of the area affected; 2- stain between 1/3 and 2/3 of the area affected; and 3 - stain more than 2/3 of area affected. Intensity X Area was thus analyzed on a scale of 0 (best score) to 9 (worst score).
Week 6 post treatment administration
Secondary Outcomes (7)
Overall MLSI at Week 3
Week 3 post treatment administration
Overall Facial MLSI at Week 3
Week 3 post treatment administration
Overall Facial MLSI at Week 6
Week 6 post treatment administration
Overall Interproximal MLSI at Week 3
Week 3 post treatment administration
Overall Interproximal MLSI at Week 6
Week 6 post treatment administration
- +2 more secondary outcomes
Study Arms (3)
Sodium bicarbonate/ Sodium Fluoride toothpaste
OTHERMarketed Sodium bicarbonate toothpaste containing 1400 parts per million (ppm) fluoride as Sodium fluoride (NaF)
Sodium fluoride toothpaste
ACTIVE COMPARATORNon-sodium bicarbonate toothpaste containing 1450ppm fluoride as NaF
Chlorhexidine digluconate mouthwash
OTHER0.2% w/v Chlorhexidine digluconate mouthwash for rinsing post-brushing with study toothpastes
Interventions
Toothpaste containing sodium bicarbonate and sodium fluoride as cosmetic
Mouthwash containing chlorhexidine digluconate
Eligibility Criteria
You may qualify if:
- Good oral health in the opinion of the investigator (excluding gingivitis)
- A minimum of 11 of the 12 permanent gradable anterior teeth at screening
- Stain levels on the buccal surfaces of the 6 maxillary and 6 mandibular anterior teeth need to be at least "mild" and present on a minimum of 4 teeth
- Modification of the Lobene Stain Index - At Visit 2, a baseline total MLSI Intensity x Area score (four sites per tooth) of greater than or equal to 8 for facial surfaces of anterior teeth.
You may not qualify if:
- Pregnant women or women who are intending to become pregnant over the duration of the study
- Known or suspected intolerance or hypersensitivity to Chlorhexidine or other study materials (or closely related compounds).
- Current use of Chlorhexidine, Cetylpyridinium Chloride or any marketed mouthwash
- Past or current use of any drug which is known to be associated with tooth discolouration within 30 days of screening or during the study period.
- Recent history (within the last 1 year) of alcohol or other substance abuse
- Dental conditions / disease requiring immediate treatment; Crowns or veneers on more than one anterior tooth; pre-existing sensitivity to oral care products; severe periodontitis; severe recession; dental implants; active carious lesions on anterior teeth; oral lesions/manifestations; prone to aphthous stomatitis and ulceration etc.
- Participant with untreated oral mucosal disease which in the opinion of the investigator could interfere with the study.
- Medical condition which would require the use of prophylactic antibiotics prior to dental cleanings
- Current or relevant history of any serious, severe or unstable physical or psychiatric illness or any medical disorder that would make the participant unlikely to fully complete the study or any condition that presents undue risk from the study treatment or procedures in the opinion of the investigator or dental assessor.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GlaxoSmithKlinelead
Study Sites (3)
Intertek 4-Front Research - Widnes
Widnes, Cheshire, WA8 6PG, United Kingdom
Intertek - Maldon (formerly 4 Front Research Ltd)
Maldon, Essex, CM9 5PN, United Kingdom
Intertek - Manchester Science Park
Manchester, M15 6SE, United Kingdom
Related Publications (1)
Akwagyiram I, Butler A, Maclure R, Colgan P, Yan N, Bosma ML. A randomised clinical trial to evaluate the effect of a 67 % sodium bicarbonate-containing dentifrice on 0.2 % chlorhexidine digluconate mouthwash tooth staining. BMC Oral Health. 2016 Aug 25;16(1):79. doi: 10.1186/s12903-016-0271-3.
PMID: 27557865DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- GSK Response Center
- Organization
- GlaxoSmithKline
Study Officials
- STUDY DIRECTOR
GSK Clinical Trials
GlaxoSmithKline
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2013
First Posted
October 14, 2013
Study Start
September 1, 2013
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
March 3, 2015
Results First Posted
November 3, 2014
Record last verified: 2015-02